METHOD FOR ASSAYING COMPOUNDS OR AGENTS FOR ABILITY TO DECREASE THE ACTIVITY OF MI- CROSOMAL PROSTAGLANDIN E SYNTHASE OR HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE

Details for Australian Patent Application No. 2003258278 (hide)

Owner AVENTIS PHARMACEUTICALS INC.

Inventors Sabol, Jeffrey S.; Li, Zhuyin; Ma, Y. Henry; Xiong, Junjie

Agent Watermark

Pub. Number AU-A-2003258278

PCT Number PCT/US03/25766

PCT Pub. Number WO2004/016223

Priority 60/404,008 16.08.02 US; 0229244.9 16.12.02 GB

Filing date 15 August 2003

Wipo publication date 3 March 2004

Event Publications

13 November 2003 Complete Application Filed

  Priority application(s): 60/404,008 16.08.02 US; 0229244.9 16.12.02 GB

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2003258278

24 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003258279-MODULAR BELT CARRIER FOR ELECTRONIC COMPONENTS

2003258277-SMART CARD WITH NRSS DELAY LINE FOR DATA ALIGNMENT